InvestorsHub Logo
Followers 840
Posts 120465
Boards Moderated 18
Alias Born 09/05/2002

Re: jbog post# 17577

Thursday, 08/10/2017 4:36:44 PM

Thursday, August 10, 2017 4:36:44 PM

Post# of 20689
No one is making money on enoxaparin anymore. AMPH admitted on yesterday's CC that is losing money on enoxaparain, but said it would lose even more money if it stopped producing. (I.e., the product produces cash flow that contributes to fixed costs.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”